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ABSTRACT
OBJECTIVES
To evaluate the evidence for the resuscitation of patients 
with hip fracture in the preoperative or perioperative phase 
of their treatment and its impact on mortality.
Design We searched MEDLINE, EMBASE, CENTRAL 
and PROSPERO databases using a systematic search 
strategy for randomised trials and observational studies 
investigating the fluid resuscitation of any patient with hip 
fracture. No language limits were applied to the search, 
which was complemented by manually screening the 
reference lists of appropriate studies.
Outcome measures Mortality at 1 week, 30 days and 
1 year following surgery.
Results Two hundred and ninety-eight citations were 
identified, and 12 full manuscripts were reviewed; no 
studies satisfied the inclusion criteria. The background 
literature showed that the mortality for these patients at 
30 days is approximately 8.5% and that bone cement 
implantation syndrome is insufficient to explain this. 
The literature was explored to define the need for 
an interventional investigation into the preoperative 
resuscitation of patients with hip fracture.
Conclusions Patients with hip fracture show similar 
physiological disturbance to major trauma patients. 
Nineteen per cent of patients presenting with hip fracture 
are hypoperfused and 50% show preoperative anaemia 
suggesting that under resuscitation is a common problem 
that has not been investigated. A properly conducted 
interventional trial could improve the outcome of these 
vulnerable patients.
INTRODUCTION
The scale of the problem
Across England, 65 000 people suffer a hip 
fracture every year, with a cost to the National 
Health Service of approximately £2 billion.1 
While some of these fractures occur in 
younger patients, the majority occur in elderly 
adults, with a mean age at presentation of 80 
years. A best practice tariff for fragility hip 
fractures was introduced in 2010 with the aim 
of encouraging prompt surgery and appro-
priate involvement of geriatric medicine 
specialists.2 Despite the improvements in the 
care of patients with hip fractures since then, 
the diagnosis is still considered by some to be 
a preterminal event with a 30-day mortality 
of 8% (equating to over 5000 deaths per 
year) and a 1-year mortality of approximately 
20%.3 4
The care pathway of these patients is 
complicated. Patients are typically frail and 
generally have multiple comorbidities, poly-
pharmacy and are often living dependently 
at the time of injury.3–8 Forty per cent shows 
cognitive impairment and 20% will present 
with an acute delirium. Despite these data 
suggesting that a hip fracture is a potentially 
devastating event with multiple factors influ-
encing overall outcome and survival, this 
population continues to be managed as if the 
hip fracture was an isolated, skeletal injury.
In contrast, patients who sustain major 
trauma or multiple fractures, where multiple 
pathologies influence outcomes, are routinely 
managed in a secondary and tertiary trauma 
network with multidisciplinary input and 
aggressive resuscitation strategies. In recent 
years, this has led to an improvement in 
their outcomes and a marked reduction in 
mortality.9
It has been established that hip fracture 
in elderly adult patients causes a similar 
physiological insult as major trauma does in 
younger patients and so should be consid-
ered equivalent to major trauma.10 11 For 
young patients who sustain major trauma, 
the primary early cause of death is shock, 
which modern protocols tackle with early 
aggressive fluid resuscitation.12 Furthermore, 
as a result of military practices, modern 
civilian trauma protocols dictate that patients 
who need intravenous resuscitation on the 
assumption of shock in major trauma are 
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Strengths and limitations of this study
 ► This review addresses a significant public health 
disease with a very poor prognosis.
 ► Thorough literature search revealed no relevant 
articles.
 ► Current practice has no evidence base and requires 
a clinical trial to inform it.
 ► A small improvement in mortality would lead to a 
large real number of patients surviving.
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resuscitated with blood rather than crystalloid or colloid 
fluids prior to the receipt of laboratory or point of care 
testing results.13–17
A hip fracture, in an elderly, vulnerable patient, consti-
tutes a major traumatic event. While definitive evidence 
is absent, it is strongly suggested that from the work in 
patients who have sustained major traumatic injuries 
that patients who are under resuscitated have worse 
outcomes and that resuscitation is most effective when it 
is performed with blood rather than crystalloid or colloid 
fluids.13–15 18 19 It then follows that early and appropriate 
resuscitation in the elderly hip fracture population, 
tempered by attention to their fragile cardiovascular 
system, has the potential to improve survivorship and 
perhaps overall outcome.
We have conducted a literature review to identify rele-
vant evidence supporting the use of blood resuscitation in 
adult patients aged 65 years and over who have presented 
within 24hours of sustaining a fracture of the proximal 
femur when compared with crystalloid or colloid resus-
citation. Furthermore, we describe our experience and 
results of performing a pilot study investigating this inter-
vention, a patient’s perspective of the clinical problem 
and present strategies used in initiating and maintaining 
the investigation.
METHODS
The first step in conducting the investigation was a review 
of relevant existing evidence. To conduct a comprehen-
sive study of the evidence, we performed a systematic 
review with narrative review of the literature. Our review 
was conducted in accordance with preferred reporting 
for systematic reviews and meta-analyses (PRISMA) guide-
lines.20
No protocol was registered for the review because of 
its small size. We then identified a precise population, 
intervention, comparator, outcome (PICO) question. In 
this review, we stipulated the question as: in patients aged 
≥65 years presenting with fracture of the proximal femur 
who are resuscitated with blood products compared with 
crystalloid, colloid or other intravenous fluid prior or 
during surgery, are 30-day mortality and morbidity rates 
reduced?
Using the OVID portal (Wolters Kluwer, Alphen aan 
den Rijn, The Netherlands), the MEDLINE (1950–
present), EMBASE (1980–2015 week 16), PROSPERO 
(no date limits) and CENTRAL (no date limits) data-
bases were searched for articles using a systematic search 
strategy. The search defined the population as those 
with hip fracture and mapped this to Medical Subject 
Headings (MeSH) terms and defined the intervention 
as fluid administration and/or resuscitation with this 
and synonyms mapped to MeSH (online supplemen-
tary appendix 1). No language limits were placed on 
the searches. We complemented the search by manually 
scanning reference lists of identified articles for relevant 
publications.
The titles of articles identified by the search strategy 
were then screened by a single author (BR) to verify inclu-
sion into the review. The abstracts of titles that showed 
potential for inclusion were then reviewed by a single 
author (BR). For those papers where the abstract was 
insufficient to confidently either include or exclude from 
the review, the full manuscript was sourced (figure 1). Any 
ambiguity for inclusion was resolved through discussion 
between all authors. Data were to be collected through a 
custom designed data collection tool by a single author 
(BR). Bias was to be assessed through the same tool, and 
its influence included within the narrative analysis. The 
assessment of bias was based on the criteria laid out by the 
Critical Appraisal Skills Programme.21 22
Outcomes analysed were to include unadjusted 30-day 
mortality and length of stay as a surrogate for function 
and morbidity. Summary measures anticipated to be used 
were ORs. Any assessment of health economics would also 
be analysed. Subgroup analysis of the very elderly patients 
(aged ≥80 years) would be performed in the event that 
these data were available.
RESULTS
Despite widespread focus on the care in this population 
in the developed world, a systematic search of the liter-
ature shows that preoperative resuscitation in the frail 
elderly patient with hip fracture has been overlooked. 
The search did not yield any articles that investigated fluid 
resuscitation or the use of blood as a fluid for resuscita-
tion prior to surgery in adults aged ≥65 years presenting 
with hip fracture, and none assessed the impact of modi-
fying preoperative fluid resuscitation on mortality or 
functional outcomes in this population. References to 
fluid resuscitation focused on anaesthetic techniques and 
the monitoring of fluid administration. Most articles do 
not identify preoperative resuscitation in these patients 
as an opportunity to modify outcomes. The existing liter-
ature focuses on blood transfusion (as opposed to blood 
resuscitation) as a treatment for established anaemia or 
investigates techniques and strategies for controlling the 
postoperative administration of intravenous fluid.
Inadequate resuscitation is easily missed in this patient 
group and would be rapidly and safely treated in any 
other age group with the same relative traumatic insult; 
however, standard practice in hip fracture care is to main-
tain the existing fluid status of patients using intravenous 
saline.12 23–26 While the literature does not specifically 
investigate resuscitation in hip fracture, it does offer some 
supporting evidence for early blood product resuscitation 
in this vulnerable group.
The blood loss associated with a hip fracture has been 
quantified. Kumar et al showed that the average haemo-
globin concentration fell by 2.23 g/dL in subtrochanteric 
fractures, 1.1 g/dL in intertrochanteric fractures and 
0.7 g/dL in intracapsular fractures following admis-
sion but before surgery. Foss et al suggested that this 
only worsens with treatment due to blood loss during 
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hip fracture surgery ranging from 547 to 1473 mL.27 28 
Irrison et al showed that the haemoglobin concentration 
follows a linear decline in the first 3 days postoperatively, 
suggesting that measuring haemoglobin concentration 
24 hours will not detect incomplete postoperative resus-
citation.29
Inadequate resuscitation leads to a relative hypovo-
laemia that is likely to have two fundamental consequences: 
hypoperfusion (shock) and reduced oxygen carrying 
capacity, which exacerbates the effects of the hypoper-
fusion. Overt shock in hip fracture is uncommon in the 
absence of other injuries. Occult shock (ie, shock not 
evident on examination or non-invasive investigation) is 
defined by a serum lactate higher than 2.5 mmol/L. It is 
associated with a significant increase in the risk of death, 
is more common than overt shock and is under diag-
nosed.23 30–35 Uzoigwe et al showed that there is a 1.2-fold 
increase in the odds of death per 1 mmol/L increase in 
serum lactate in elderly hip fracture patients, a trend 
also observed by other authors,.31 36 Salottolo et al showed 
that in elderly trauma patients, a lactate of ≥2.5 mmol/L 
led to a 2.62-fold increase in the odds of mortality and 
that failure to recognise occult hypoperfusion led to an 
increase in mortality in elderly patients from 12% to 
35%.11 23 Venkatesan et al investigated the association 
between the recorded lactate level and mortality in the 
hip fracture population and found that 19% of hip frac-
ture patients showed a lactate of >3.0 mmol/L and that 
these patients showed a mortality 4.5 times greater than 
those with a lactate of <3.0 mmol/L when covariates of 
interest were adjusted for (6% vs 28%).30
The effect of inadequate resuscitation is exacerbated by 
the reduced ability of the circulation to deliver oxygen to 
the end organs with a low serum haemoglobin concen-
tration. Some evidence exists to support this position in 
the context of anaemia. Anaemia is common among the 
elderly, affecting 17% of all patients aged over 65 years, 
rising to 50% in patients presenting with hip fracture, 
in turn leading to compromised patient outcomes and 
an increased risk of mortality.5 6 37 38 The scale of this 
increased mortality is best described by a meta-anal-
ysis of 10 studies investigating patients with hip fracture 
produced by Potter et al in 2015, showing that preopera-
tive anaemia is associated with an increase in the relative 
risk of mortality of 1.64 (95% CI 1.47 to 1.82) at all time 
points beyond 30 days.39 Similar effects are seen in elderly 
Figure 1 The preferred reporting for systematic reviews and meta-analyses (PRISMA) diagram representing the systematic 
literature search.
group.bmj.com on May 5, 2017 - Published by http://bmjopen.bmj.com/Downloaded from 
4 Rocos B, et al. BMJ Open 2017;7:e015906. doi:10.1136/bmjopen-2017-015906
Open Access 
patients in other surgical cohorts with anaemia causing 
an increase in mortality of between 6% and 182% using a 
variety of study designs.40–45
Adequate resuscitation has a role in reducing the risk 
bone cement implantation syndrome (BCIS), a condition 
of ill-defined aetiology associated with an increase in very 
early postoperative mortality.46 This syndrome may occur 
when the cement that is used to fix in place the femoral 
stem of patients treated for displaced intracapsular hip 
fractures is inserted. There is no agreed definition of 
BCIS; however, it is characterised by hypoxia, hypoten-
sion, cardiac arrhythmias, increased pulmonary vascular 
resistance and cardiac arrest in response to cement or 
prosthesis implantation at arthroplasty.47 It is generally 
accepted that the pathophysiological process involved 
is as a result of embolism caused by high intramedul-
lary pressures during cementation.47 The risk of BCIS is 
thought to be reduced by two strategies. One is to alter 
the surgical field to reduce the risk of embolisation by 
the use of pulsatile lavage, a suction catheter as well as 
a retrograde cementation technique.48 The second is to 
ensure adequate fluid resuscitation and maintenance 
of an adequate blood pressure at the time of cement 
insertion, failure to do this is associated with excess early 
death.46 47 The effect of goal-directed intraoperative fluid 
administration is as yet unclear. Sinclair et al showed in a 
40-patient prospective randomised trial that goal-directed 
restoration of optimal stroke volume reduced length of 
stay and improved postoperative recovery.49 This conclu-
sion was challenged by Price et al in a 2004 Cochrane 
Review, which concluded that there was no evidence for 
using goal-directed intraoperative fluid therapy over a 
traditional approach.35 More recently, this conclusion 
has been confirmed by Moppett et al and Bartha et al51 
who both showed in a larger trial that goal-directed fluid 
therapy does not confer any appreciable benefit.50
BCIS does not explain the excess mortality rate in 
patients with hip fracture. In a large study of over 25 000 
patients using the Australian Orthopaedic Association 
National Joint Replacement Registry, Costain et al were 
able to show that cemented hemiarthroplasty showed 
equivalent mortality to uncemented prostheses (where 
BCIS cannot occur) at 7 days and 1 month following 
surgery, and a reduced mortality at 1 year.52 Other mech-
anisms must have a role in influencing the high mortality 
observed in these patients.
Preoperative resuscitation using crystalloid, colloid 
fluids or blood products has the potential to treat 
hypovolaemia, anaemia and BCIS.29 39 53–56 Crystalloids 
and colloid fluids do not remain in the circulation for 
long and fail to address the reduced oxygen carrying 
capacity,.13 14 16 17 Despite the fall in 2,3-diphosphoglyc-
erate (2,3-DPG) concentration in stored blood, the 
sustained improvement in haemodynamics through the 
timely administration of blood should lead to improved 
end organ perfusion.53 57 58 If a survival advantage exists, 
then administering appropriate fluid resuscitation preop-
eratively may prevent deterioration before appropriate 
treatment can be commenced and prevent irreversible 
decline in function and the associated increased risk of 
mortality. The 2015 Cochrane Review by Brunskill et al59 
concluded that further research was needed into blood 
product resuscitation in the preoperative phase of hip 
fracture care to include frail, unstable and cognitively 
impaired patients in an effort to improve mortality and 
functional outcomes. This conclusion is supported by 
Parker et al55, the FOCUS trial and Potter et al39, each 
of which concludes that a trial investigating preoper-
ative blood product resuscitation in patients with hip 
fracture should take place to investigate potential 
improvements in the outcomes for these vulnerable 
patients.56
Understandably, it would be reasonable to expect the 
medical community to be reluctant to administer blood 
products to patients outside the traditional indications 
because of the risk of complications and side effects. 
However, the published refutes these hypotheses and 
shows that blood administration in elderly adult patients 
shows no increase in the risk of transfusion-related illness. 
The Transfusion Requirements in Frail Elderly (TRIFE) 
study showed no increase in transfusion-related compli-
cations in patients with hip fracture when compared with 
a control group.60 This is confirmed by the TITRe2 trial, 
the FOCUS trial and by Parker and colleagues who carried 
out a study in the elderly hip fracture cohort and showed 
no increase in complications with a protocol-driven trans-
fusion strategy rather than a clinically guided (more 
restrictive) strategy.55 56 61 62 Potter et al noted that trials to 
date, which have shown an increase in morbidity due to 
transfusion, are influenced by uncontrolled confounding 
factors,39 and Jansen and colleagues describe how the 
immunological dysfunction attributed to blood adminis-
tration applies only in massive transfusion.13
While the literature is unable to inform the use of 
blood product in the preoperative resuscitation of elderly 
adults presenting with hip fracture, it is able to provide 
an informed foundation on which subsequent investi-
gations can be built. There is a case for interventional 
trial looking at the effect of preoperative blood product 
resuscitation in patients with hip fracture with the aim of 
reducing mortality and improving functional outcomes in 
answer to their pathophysiology following injury. Equally, 
there remains sufficient equipoise in using blood prod-
ucts for resuscitation in major trauma for an investigation 
specific to this patient group to be justified. The use of 
blood products in this age group is safe and is unlikely to 
lead to subsequent disease, and the scale of the clinical 
and socioeconomic burden of this condition is such that 
an interventional trail with the aims of reducing mortality 
and morbidity is a reasonable proposal.
CONCLUSION
The literature contains no evidence of any study that has 
investigated the effects of preoperative resuscitation in 
older adult patients presenting with hip fracture, despite 
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the high early mortality associated with this injury. Elderly 
patients are vulnerable to inadequate resuscitation, 
and from the evidence describing the status of patients 
with hip fracture and resuscitation in major trauma, we 
hypothesise that there are advantages to the early appro-
priate resuscitation of patients with hip fracture. In the 
absence of any literature or evidence that this is likely to 
have a deleterious effect, there is sufficient equipoise for 
the conduct of a randomised controlled trial to establish 
whether standard care pathways or preoperative resusci-
tation with blood products in elderly patients with a hip 
fracture is superior.
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